Skip to content

Clinical trials

Phase 2 Hepatitis B trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 2 Country / region: China Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20091
20101
20121
20153
20161
20171
20181
20191
20206
20213
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated5
Unknown status5
Active, not recruiting3
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Arrowhead Pharmaceuticals4
Brii Biosciences Limited3
Aligos Therapeutics1
Ascentage Pharma Group Inc.1
Assembly Biosciences1
Ausper Biopharma Co., Ltd.1
AusperBio Therapeutics Inc.1
Centers for Disease Control and Prevention1
Hospital Authority, Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B28
Hepatitis B, Chronic12
Carcinoma, Hepatocellular3
Hepatitis3
Infections3
Acute-On-Chronic Liver Failure1
Blood-Borne Infections1
Bronchiolitis Obliterans Syndrome1
Chronic Disease1
Communicable Diseases1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.